Sharon Chen
CEOFormer Director of Google Shanghai R&D Institute; Former General Manager of Verily China
About Company
AlphaLife Sciences is revolutionizing the intersection of life sciences and advanced computer science with AuroraPrime, our premier GenAI-powered SaaS platform for clinical research. Our state-of-the-art GenAI-driven medical writing solutions are trusted by leading pharmaceutical companies to enhance precision, streamline workflows, and accelerate drug development.
Supported by industry leaders such as Microsoft for Startups (Pegasus Program), Google for Startups, Johnson & Johnson Innovation - JLABS, and the Nvidia Inception Program, we leverage cutting-edge GenAI, cloud computing, and robust data platforms to transform clinical trials. Our technology automates complex processes, reduces time-to-market, and delivers unmatched efficiency, providing strategic advantages to big pharma companies.
Partner with AlphaLife Sciences to harness the full potential of GenAI and drive unparalleled innovation and success in your pharmaceutical endeavors.
Mission
For clinical research and post-market real-world research, AlphaLife Science Group focuses on building a SaaS platform serving life sciences and consumer health fields with the world's leading computer technology, and realizing process automation and intelligent decision-making driven by clinical research docs and data.
Leadership Team
Alice Hsu
SVP, Clinical Technology ServicesFormer Head of Project Management and Clinical Operation at WuXi Clinical; Former PD of Project Management at Covance (Fortrea)
Murali Krishnam
SVP, GTM Strategy and OperationFormer Co-Founder of Saama; Former executive team member at ThoughtSphere
Pengcheng Xu
Chief Technology OfficerThe first engineer at Google China; Former Architect at Verily China
Bogong Zhu
Chief Product OfficerFormer Cloud AI Tech Lead at Google Shanghai; Former Clinical Software Tech Lead at Verily China
Gavin Zhang
Chief Business Officer, JAPACFormer Head of Channel Sales Asia Pacific of Medidata; Former Key Account Solution Sales at Microsoft
Advisory Board
Ruyi He
Chief Strategy Officer of RemeGen; FormerDeputy Director of FDA’s Division of Gastrointestinal and Coagulation Drug Products, Former MD Chief Scientist of CDE
Névine Zariffa
Board member of CDISC; Former SVP, Head of Biometrics & Information Sciences at AstraZeneca
Kun He
CEO and Chief Statistician of R&G; Former Associate Division Director of the Division of Biometrics V at CDER, FDA
Brand Story
In 2020, a group of senior technology and product experts from Google and Verily China decided to start a business and delve into the intelligent digitalization of life science clinical research. With the goal of building a SaaS platform for life science and consumer health fields through world-leading computer technology, AlphaLife Sciences was officially established in August 2020. With the vision of "Use technology to advance innovation in life science and consumer health. Faster, more accessible and evidence-based," the AlphaLife team quickly grew and attracted many technology talents from leading global IT companies and senior industry experts from the life sciences field. With the gradual launch of AlphaLife's innovative products, more and more leading life science innovation and development companies, as well as ecosystem partners, choose AlphaLife, collaborate in multiple ways, and jointly explore the future of intelligent digitalization in clinical research.
Our global network and support
With experienced staff and trusted partners worldwide, we provide comprehensive support to ensure you have the resources you need, wherever you are.
- New Jersey
- San Francisco
- Singapore
- Shanghai
- Beijing
- Taipei
Part of our investment partners
-
B Capital Group
-
Lightspeed China Partners
-
Hankang Capital